| Mr Marc Peluso, CRNA | |
|
101 Nicolls Rd, Stony Brook, NY 11794-0001 | |
| (631) 689-8333 | |
| Not Available |
| Full Name | Mr Marc Peluso |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 14 Years |
| Location | 101 Nicolls Rd, Stony Brook, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851691430 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 544166-1 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ns/lij Hs Southside Hospital | Bay shore, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Shore - Lij Anesthesiology, Pc | 1153602453 | 779 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
ZIOPHARM Oncology, Inc. announced today that it intends to offer shares of its common stock and warrants to purchase shares of its common stock in a public offering. JMP Securities LLC and Rodman & Renshaw, LLC are acting as co-lead managers for the offering.
I applaud Chairman Baucus and his working group of senators for their bipartisan work on health reform. By introducing a bill today, Chairman Baucus has moved our nation forward on the difficult yet important road to reform.
ProFibrix B.V., a leader in the development of innovative bioactive products to stop bleeding (hemostasis), today announced the start of its pivotal Phase III clinical trial with Fibrocaps (FINISH-3) in spine, liver, vascular and soft tissue surgery.
The Associated Press reports on "the national surge in elderly inmates whose medical expenses are straining cash-strapped states and have officials looking for solutions, including early release, some possibly to nursing homes. ... That burden is becoming greater as the American Civil Liberties Union estimates that elderly prisoners — the fastest growing segment of the prison population, largely because of tough sentencing laws — are three times more expensive to incarcerate than younger inmates.
› Verified 5 days ago
| Entity Name | Long Island Anesthesia Physicians Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952387276 PECOS PAC ID: 7113825381 Enrollment ID: O20040106000103 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
ZIOPHARM Oncology, Inc. announced today that it intends to offer shares of its common stock and warrants to purchase shares of its common stock in a public offering. JMP Securities LLC and Rodman & Renshaw, LLC are acting as co-lead managers for the offering.
I applaud Chairman Baucus and his working group of senators for their bipartisan work on health reform. By introducing a bill today, Chairman Baucus has moved our nation forward on the difficult yet important road to reform.
ProFibrix B.V., a leader in the development of innovative bioactive products to stop bleeding (hemostasis), today announced the start of its pivotal Phase III clinical trial with Fibrocaps (FINISH-3) in spine, liver, vascular and soft tissue surgery.
The Associated Press reports on "the national surge in elderly inmates whose medical expenses are straining cash-strapped states and have officials looking for solutions, including early release, some possibly to nursing homes. ... That burden is becoming greater as the American Civil Liberties Union estimates that elderly prisoners — the fastest growing segment of the prison population, largely because of tough sentencing laws — are three times more expensive to incarcerate than younger inmates.
› Verified 5 days ago
| Entity Name | North American Partners In Anesthesia Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649264706 PECOS PAC ID: 7719885771 Enrollment ID: O20040108000176 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
ZIOPHARM Oncology, Inc. announced today that it intends to offer shares of its common stock and warrants to purchase shares of its common stock in a public offering. JMP Securities LLC and Rodman & Renshaw, LLC are acting as co-lead managers for the offering.
I applaud Chairman Baucus and his working group of senators for their bipartisan work on health reform. By introducing a bill today, Chairman Baucus has moved our nation forward on the difficult yet important road to reform.
ProFibrix B.V., a leader in the development of innovative bioactive products to stop bleeding (hemostasis), today announced the start of its pivotal Phase III clinical trial with Fibrocaps (FINISH-3) in spine, liver, vascular and soft tissue surgery.
The Associated Press reports on "the national surge in elderly inmates whose medical expenses are straining cash-strapped states and have officials looking for solutions, including early release, some possibly to nursing homes. ... That burden is becoming greater as the American Civil Liberties Union estimates that elderly prisoners — the fastest growing segment of the prison population, largely because of tough sentencing laws — are three times more expensive to incarcerate than younger inmates.
› Verified 5 days ago
| Entity Name | Long Island Digestive Endoscopy Center Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1235551052 PECOS PAC ID: 3971728221 Enrollment ID: O20140701000364 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
ZIOPHARM Oncology, Inc. announced today that it intends to offer shares of its common stock and warrants to purchase shares of its common stock in a public offering. JMP Securities LLC and Rodman & Renshaw, LLC are acting as co-lead managers for the offering.
I applaud Chairman Baucus and his working group of senators for their bipartisan work on health reform. By introducing a bill today, Chairman Baucus has moved our nation forward on the difficult yet important road to reform.
ProFibrix B.V., a leader in the development of innovative bioactive products to stop bleeding (hemostasis), today announced the start of its pivotal Phase III clinical trial with Fibrocaps (FINISH-3) in spine, liver, vascular and soft tissue surgery.
The Associated Press reports on "the national surge in elderly inmates whose medical expenses are straining cash-strapped states and have officials looking for solutions, including early release, some possibly to nursing homes. ... That burden is becoming greater as the American Civil Liberties Union estimates that elderly prisoners — the fastest growing segment of the prison population, largely because of tough sentencing laws — are three times more expensive to incarcerate than younger inmates.
› Verified 5 days ago
| Entity Name | North Shore - Lij Anesthesiology, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417401266 PECOS PAC ID: 1153602453 Enrollment ID: O20161228001498 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
ZIOPHARM Oncology, Inc. announced today that it intends to offer shares of its common stock and warrants to purchase shares of its common stock in a public offering. JMP Securities LLC and Rodman & Renshaw, LLC are acting as co-lead managers for the offering.
I applaud Chairman Baucus and his working group of senators for their bipartisan work on health reform. By introducing a bill today, Chairman Baucus has moved our nation forward on the difficult yet important road to reform.
ProFibrix B.V., a leader in the development of innovative bioactive products to stop bleeding (hemostasis), today announced the start of its pivotal Phase III clinical trial with Fibrocaps (FINISH-3) in spine, liver, vascular and soft tissue surgery.
The Associated Press reports on "the national surge in elderly inmates whose medical expenses are straining cash-strapped states and have officials looking for solutions, including early release, some possibly to nursing homes. ... That burden is becoming greater as the American Civil Liberties Union estimates that elderly prisoners — the fastest growing segment of the prison population, largely because of tough sentencing laws — are three times more expensive to incarcerate than younger inmates.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Marc Peluso, CRNA 101 Nicolls Rd, Stony Brook, NY 11794-0001 Ph: () - | Mr Marc Peluso, CRNA 101 Nicolls Rd, Stony Brook, NY 11794-0001 Ph: (631) 689-8333 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
ZIOPHARM Oncology, Inc. announced today that it intends to offer shares of its common stock and warrants to purchase shares of its common stock in a public offering. JMP Securities LLC and Rodman & Renshaw, LLC are acting as co-lead managers for the offering.
I applaud Chairman Baucus and his working group of senators for their bipartisan work on health reform. By introducing a bill today, Chairman Baucus has moved our nation forward on the difficult yet important road to reform.
ProFibrix B.V., a leader in the development of innovative bioactive products to stop bleeding (hemostasis), today announced the start of its pivotal Phase III clinical trial with Fibrocaps (FINISH-3) in spine, liver, vascular and soft tissue surgery.
The Associated Press reports on "the national surge in elderly inmates whose medical expenses are straining cash-strapped states and have officials looking for solutions, including early release, some possibly to nursing homes. ... That burden is becoming greater as the American Civil Liberties Union estimates that elderly prisoners — the fastest growing segment of the prison population, largely because of tough sentencing laws — are three times more expensive to incarcerate than younger inmates.
› Verified 5 days ago
Joreene Jasmin, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: Health Science Tower, Level 4 Room 060, Stony Brook, NY 11794 Phone: 305-609-7617 | |
Lauren Logue, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 101 Nicolls Rd, Stony Brook, NY 11794 Phone: 631-444-2975 | |
Caitlin Janosick, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 101 Nicolls Rd, Stony Brook, NY 11794 Phone: 631-689-8333 | |
Mrs. Valerie Capozzoli, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: Stony Brook University Hospital, Stony Brook, NY 11794 Phone: 631-708-6196 Fax: 631-589-2021 | |
Anna Buono, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 101 Nicolls Rd, Stony Brook, NY 11794 Phone: 631-444-4000 | |
Stephen Quiery, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 24 Old Wood Rd, Stony Brook, NY 11790 Phone: 631-356-4590 | |
Ashley Zarkowski, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 101 Nicolls Rd, Stony Brook, NY 11794 Phone: 631-444-4000 |